Francesca Marzoli

Dr. Francesca Marzoli


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
EFEleonora Foglio
Eleonora Foglio
GPGiovanni Puddighinu
Giovanni Puddighinu
PFPasquale Fasanaro
Pasquale Fasanaro
DDDaniela D’Arcangelo
Daniela D’Arcangelo
GPGiulietta A. Perrone
Giulietta A. Perrone
FLFederica Limana
Federica Limana

9 February 2015 in Oncogene
Verified
Journal Article
Closed access
FLF Lozupone
F Lozupone
MBMartina Borghi
Martina Borghi
FMFrancesca Marzoli
Francesca Marzoli
TAT Azzarito
T Azzarito
PMPaola Matarrese
Paola Matarrese
Stefano FaisStefano Fais
Stefano Fais

1 October 2017 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SPStefano Pieretti
Stefano Pieretti
ARAmalendu P. Ranjan
Amalendu P. Ranjan
AGAmalia Di Giannuario
Amalia Di Giannuario
AMAnindita Mukerjee
Anindita Mukerjee
FMFrancesca Marzoli
Francesca Marzoli
Jamboor VishwanathaJamboor Vishwanatha
Jamboor Vishwanatha

8 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Azzurra StefanucciAzzurra Stefanucci
Azzurra Stefanucci
Wei LeiWei Lei
Wei Lei
SPStefano Pieretti
Stefano Pieretti
ENEttore Novellino
Ettore Novellino
MDMarilisa Pia Dimmito
Marilisa Pia Dimmito
Adriano MollicaAdriano Mollica
Adriano Mollica
Here, we report the chemical synthesis of two DPDPE analogues 7a (NOVA1) and 7b (NOVA2). This entailed the solid-phase synthesis of two enkephalin precursor chains followed by a CuI-catalyzed azide-alkyne cycloaddition, with the aim of improving in vivo analgesic efficacy versus DPDPE. NOVA2 showed good affinity and selectivity for the μ-opioid receptor (KI of 59.2 nM, EC50 of 12.9 nM, EMax of 87.3%), and long lasting anti-nociceptive effects in mice when compared to DPDPE.

26 May 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
LCLaura Ciarlo
Laura Ciarlo
FMFrancesca Marzoli
Francesca Marzoli
PMPaola Minosi
Paola Minosi
PMPaola Matarrese
Paola Matarrese
SPStefano Pieretti
Stefano Pieretti
Glycyrrhiza glabra, commonly known as liquorice, contains several bioactive compounds such as flavonoids, sterols, triterpene, and saponins; among which, glycyrrhizic acid, an oleanane-type saponin, is the most abundant component in liquorice root. Diabetic peripheral neuropathy is one of the major complications of diabetes mellitus, leading to painful condition as neuropathic pain. The pathogenetic mechanism of diabetic peripheral neuropathy is very complex, and its understanding could lead to a more suitable therapeutic strategy. In this work, we analyzed the effects of ammonium glycyrrhizinate, a derivate salt of glycyrrhizic acid, on an in vitro system, neuroblastoma cells line SH-SY5Y, and we observed that ammonium glycyrrhizinate was able to prevent cytotoxic effect and mitochondrial fragmentation after high-glucose administration. In an in vivo experiment, we found that a short-repeated treatment with ammonium glycyrrhizinate was able to attenuate neuropathic hyperalgesia in streptozotocin-induced diabetic mice. In conclusion, our results showed that ammonium glycyrrhizinate could ameliorate diabetic peripheral neuropathy, counteracting both in vitro and in vivo effects induced by high glucose, and might represent a complementary medicine for the clinical management of diabetic peripheral neuropathy.

1 February 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
FMFrancesca Marzoli
Francesca Marzoli
Carlotta MarianecciCarlotta Marianecci
Carlotta Marianecci
Federica RinaldiFederica Rinaldi
Federica Rinaldi
Daniele PasseriDaniele Passeri
Daniele Passeri
MRMarco Rossi
Marco Rossi
SPStefano Pieretti
Stefano Pieretti
Ibuprofen is one of the non-steroidal anti-inflammatory drugs (NSAIDs) widely used to treat pain conditions. NSAIDs encounter several obstacles to passing across biological membranes. To overcome these constraints, we decided to study the effects of a new pH-sensitive formulation of niosomes containing Polysorbate 20 derivatized by Glycine and loaded with ibuprofen (NioIbu) in several animal models of pain in mice. We performed two tests commonly used to study acute antinociceptive activity, namely the writhing test and the capsaicin test. Our results demonstrated that NioIbu, administered 2 h before testing, reduced nociception, whereas the free form of ibuprofen was ineffective. In a model of inflammatory pain, hyperalgesia induced by zymosan, NioIbu induced a long-lasting reduction in hyperalgesia in treated mice. In a model of neuropathic pain induced by sciatic nerve chronic constriction, NioIbu reduced both neuropathy-induced allodynia and hyperalgesia. The results obtained in our experiments suggest that pH-sensitive niosomes containing Polysorbate 20 derivatized by Glycine is an effective model for NSAIDs delivery, providing durable antinociceptive effects and reducing the incidence of side effects.